Anacardio

Developer of drugs for heart failure treatment

placeSweden calendar_todayFounded 2017 groups11 employees language anacardio.com

Social engagement

Social engagement: 1.6K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Karolinska Development, Flerie, Industrifonden, 3B Future Health Fund.

Investor typeCountShare
Venture capital764%
Other / undisclosed436%

Recent activity

20 May 2026
Event
BIO 2026
12 May 2026
Expansion
Barcelona
10 May 2026
Event
Heart Failure Association of the ESC - HFA Congress
Coming soon